Tianlai Shi

450 total citations
7 papers, 334 citations indexed

About

Tianlai Shi is a scholar working on Molecular Biology, Epidemiology and Aging. According to data from OpenAlex, Tianlai Shi has authored 7 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Epidemiology and 3 papers in Aging. Recurrent topics in Tianlai Shi's work include Genetics, Aging, and Longevity in Model Organisms (3 papers), DNA Repair Mechanisms (2 papers) and Telomeres, Telomerase, and Senescence (2 papers). Tianlai Shi is often cited by papers focused on Genetics, Aging, and Longevity in Model Organisms (3 papers), DNA Repair Mechanisms (2 papers) and Telomeres, Telomerase, and Senescence (2 papers). Tianlai Shi collaborates with scholars based in Switzerland, United States and Sweden. Tianlai Shi's co-authors include David Shore, Stefano Mattarocci, Nicolas H. Thomä, Maksym Shyian, Christopher F. J. Hardy, Laure Lemmens, Pascal Damay, Dogus Murat Altintas, Clinton R. Bartholomew and Ulrich Rass and has published in prestigious journals such as Cell, Nature Structural & Molecular Biology and PLoS Pathogens.

In The Last Decade

Tianlai Shi

7 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tianlai Shi Switzerland	6	284	77	43	41	40	7	334
Vadim Shchepachev Switzerland	10	399 1.4×	70 0.9×	18 0.4×	17 0.4×	35 0.9×	11	441
Arianna Lockhart Germany	6	431 1.5×	153 2.0×	32 0.7×	23 0.6×	85 2.1×	7	522
Mariano Oppikofer Switzerland	11	552 1.9×	25 0.3×	17 0.4×	26 0.6×	91 2.3×	13	593
Nicole Averbeck Germany	11	270 1.0×	18 0.2×	23 0.5×	14 0.3×	35 0.9×	15	368
Andrea Panza Italy	4	354 1.2×	204 2.6×	38 0.9×	13 0.3×	61 1.5×	6	413
Beth Osia United States	8	331 1.2×	36 0.5×	10 0.2×	21 0.5×	62 1.6×	10	370
Benoît Guillemette Canada	7	668 2.4×	18 0.2×	13 0.3×	22 0.5×	148 3.7×	10	736
Michael V. Zuccaro United States	10	403 1.4×	22 0.3×	23 0.5×	15 0.4×	33 0.8×	16	476
Véra Schramke France	7	609 2.1×	124 1.6×	39 0.9×	15 0.4×	221 5.5×	7	671
Gonghong Yan United States	11	325 1.1×	14 0.2×	12 0.3×	30 0.7×	71 1.8×	15	385

Countries citing papers authored by Tianlai Shi

Since Specialization

Citations

This map shows the geographic impact of Tianlai Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianlai Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianlai Shi more than expected).

Fields of papers citing papers by Tianlai Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianlai Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianlai Shi. The network helps show where Tianlai Shi may publish in the future.

Co-authorship network of co-authors of Tianlai Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Tianlai Shi. A scholar is included among the top collaborators of Tianlai Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianlai Shi. Tianlai Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Ross, Ryan D., et al.. (2022). Trastuzumab-based regimens beyond progression: A crucial treatment option for HER2+ advanced/metastatic breast cancer. The Breast. 66. 262–271. 3 indexed citations

2.

Mecate‐Zambrano, Angeles, Guiscard Seebohm, Kevin Ciminski, et al.. (2020). Discrete spatio-temporal regulation of tyrosine phosphorylation directs influenza A virus M1 protein towards its function in virion assembly. PLoS Pathogens. 16(8). e1008775–e1008775. 9 indexed citations

3.

Kristoffersson, Anders, Caterina Bissantz, Andreas Haldimann, et al.. (2019). A novel mechanism-based pharmacokinetic–pharmacodynamic (PKPD) model describing ceftazidime/avibactam efficacy against β-lactamase-producing Gram-negative bacteria. Journal of Antimicrobial Chemotherapy. 75(2). 400–408. 16 indexed citations

4.

Javanbakht, Hassan, H. Mueller, Johanna Walther, et al.. (2018). Liver-Targeted Anti-HBV Single-Stranded Oligonucleotides with Locked Nucleic Acid Potently Reduce HBV Gene Expression In Vivo. Molecular Therapy — Nucleic Acids. 11. 441–454. 53 indexed citations

5.

Mattarocci, Stefano, R.D. Bunker, Gabriele Fontana, et al.. (2017). Rif1 maintains telomeres and mediates DNA repair by encasing DNA ends. Nature Structural & Molecular Biology. 24(7). 588–595. 45 indexed citations

6.

Mattarocci, Stefano, Maksym Shyian, Laure Lemmens, et al.. (2014). Rif1 Controls DNA Replication Timing in Yeast through the PP1 Phosphatase Glc7. Cell Reports. 7(1). 62–69. 129 indexed citations

7.

Shi, Tianlai, R.D. Bunker, Stefano Mattarocci, et al.. (2013). Rif1 and Rif2 Shape Telomere Function and Architecture through Multivalent Rap1 Interactions. Cell. 153(6). 1340–1353. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact